• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » UPDATE: Court cuts Biolase board, marketing VP under fire

UPDATE: Court cuts Biolase board, marketing VP under fire

March 24, 2014 By Arezu Sarvestani

Court halves Biolase board, marketing VP under fire

*Updated March 25, 2014 at 10 a.m. Eastern with comment from Biolase sales & marketing vice president Brian Jaffe.

Biolase (NSDQ:BIOL) continues to swat at challenges to its leadership, after a Delaware state judge cut the board of directors and a former employer took a few shots at the dental device maker’s sales & marketing head.

Biolase is enmeshed in a proxy war with activist investor Oracle Partners, which owns a 16.4% stake. Biolase said today that a Delaware court constrained its board of directors to 4 members on a "status quo" basis, pending the outcome of an Oracle lawsuit filed earlier this month. Biolase’s board was originally set at 6 seats; the dispute erupted when Oracle contested CEO Federico Pignatelli’s attempt to revoke the resignations of 2 long-time directors.

Dr. Alexander Arrow, who is also president & COO, and fellow director Dr. Sam Low resigned their seats early this month, making room for new members Jeffrey Nugent and Paul Clark. None of the 4 were given seats in the court’s new ruling.

The judge also excluded Oracle candidate Eric Varma, a partner at the investment firm, but let Oracle-backed existing member Frederic Moll keep his seat. The other 3 board seats were given to existing members Pignatelli, Norman Nemoy and James Talevich, whose "directorships are not disputed," the court said.

The Delaware Chancery Court also ruled that during the "status quo" period, the board may not undertake any new actions without the approval of at least 3 members, mandating that any decisions falling "outside of the ordinary course of the company’s business" must come with a 10-day advanced notice, according to an SEC filing.

A former employer took the hubbub over the proxy battle as an opportunity to take a few potshots at Biolase sales & marketing vice president Brian Jaffe, saying the broadside was prompted by Jaffe’s alleged poaching of a key employee at Millennium Dental Technologies.

In a phone interview today with MassDevice.com, Millennium Dental Technologies CEO Mark Monaghan had kind words for Jaffe on a personal level, but chastised him for falling out of touch before allegedly poaching a vital MDT employee.

Jaffe was on good terms with MDT following his departure, Monaghan said, maintaining a friendly tone at trade shows. Jaffe gave his former employer a head’s up when he was in talks with sales reps that he had previously interviewed while working for MDT, Monaghan told us. But the relationship changed when Jaffe hired then-MDT marketing director Rachel Moody, he alleged.

"We would have preferred that he contact us to let us know that he was targeting our head of marketing, or that she was looking for a position at Biolase before hiring her, but he did not and, as far as I know, he has not responded to any communications that [MDT president Dr. Robert Gregg] has sent him since," Monaghan told us. "Now that they’re starting to target our key employees, we felt it necessary, essentially, to come out and clarify truly the statement that was made by Biolase on Brian’s behalf."

MDT issued a press release this week that was notable for its personal tone, taking issue with Biolase’s claims about Jaffe’s tenure at MDT.

"Prior to joining Biolase, Jaffe served as Vice President of Global Sales at Millennium Dental Technologies during 2013, growing the periodontal laser sales reach by realigning and expanding the U.S. sales force and expanding international distribution," according to the Biolase website.

"Jaffe was a block in the process of growing our domestic sales, as indicated by the poor sales results compared to the prior year," Gregg said in the release. "Jaffe fought and resisted key marketing and pricing initiatives, which ultimately resulted in his departure. But he does have a noteworthy tennis forehand."

Monaghan told us that Jaffe’s stint at MDT was hardly long enough for him to have a significant impact.

"In the short 6 months that he was here, it wasn’t long enough for him, really, to understand our culture and to make a contribution," he said. "We didn’t increase our sales dramatically, we didn’t increase our sales force dramatically, we did not sign up a whole bunch of international distributors. We spent a lot of time just speaking and educating him on the way we do business, and that was about it."

Jaffe may have been a boon to the company had he stayed, Monaghan added, but he simply wasn’t around long enough to accomplish much of anything – although he did cause some ripples when he challenged the company’s training and pricing processes, Monaghan said.

"When we say he blocked progress, he wasn’t totally on board with our pricing policy," Monaghan said. "The guy who’s directing the sales force must be completely sold on the approach, and he was not."

*Jaffe agreed that the Moody’s departure was the catalyst in the falling out.

"That’s all it’s about, it’s just about Rachel’s leaving," Jaffe said. "I did not poach Rachel Moody; she applied to the company. It’s extremely unfortunate that they sent out this defamatory press release."

Jaffe maintained that he’d received much praise during his time at MDT, and that both Gregg and Monaghan explicitly told him that he was welcome back. He said he’d been in touch with both MDT executives over the course of the past 5 months and that they’d been "good friends.”

"Then, when I hire Rachel last week [Gregg] sends me this threatening text and then puts out this press release," Jaffe said. "I came to Biolase because Biolase has one of the best lasers in the world and a whole set of technology products, what we call a total technology solution. Millennium has 1 product, called the PerioLase. That’s why I left to go to Biolase, not because I was fired. It’s absurd. I left on very good terms with Millennium."

Gregg and Moody were not available for comment.

Filed Under: Legal News, News Well Tagged With: Biolase, Millennium Dental Technologies, Oracle Partners, Personnel Moves

In case you missed it

  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy
  • NuVasive chief commercial officer Massimo Calafiore is stepping down
  • Preparing your medical device company for challenging market conditions
  • Dentsply Sirona replaces chief accounting officer amid internal investigation
  • Haemonetics stock rises on Street-beating Q1, raised guidance

RSS From Medical Design & Outsourcing

  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy